Post-tPA hemorrhage in CVA: Difference between revisions
(Add MedicationDose entry for tranexamic acid) |
|||
| Line 22: | Line 22: | ||
**STAT neurosurgery consult | **STAT neurosurgery consult | ||
**Consider TXA 15 mg/kg IV in 250 ml x 20 min if ongoing hemorrhage after above measures | **Consider TXA 15 mg/kg IV in 250 ml x 20 min if ongoing hemorrhage after above measures | ||
==Medication Dosing== | |||
{{MedicationDose | |||
| drug = Tranexamic acid | |||
| dose = 15mg/kg IV in 250mL over 20 min | |||
| route = IV | |||
| context = If ongoing hemorrhage after blood products | |||
| indication = Post-tPA Hemorrhage in CVA | |||
| population = Adult | |||
}} | |||
==See Also== | ==See Also== | ||
Revision as of 21:08, 20 March 2026
Background
- Consider post-tPA ICH if patient develops:
- Decreased LOC
- Worsening neurologic exam
- Increased weakness
- New headache
- Sudden rise in BP
- May also have GI bleed, mucosal bleeding
Management
- Immediately Stop tPA, even on suspicion of post-tPA hemorrhage
- STAT Head CT
- If no bleeding: resume tPA
- If post-tPA ICH present
- Obtain baseline labs: CBC, D-dimer, type and screen, fibrinogen. Check INR 15 minutes after FFP administration (see below) and platelets 15 min after platelet administration (see below)
- Administer cryoprecipitate 10 units for fibrinogen replacement
- If fibrinogen returns > 150, discontinue, if < 150, recheck in 1 hr and if still low administer additional 20 units
- Administer FFP 20 ml/kg
- If INR > 1.4, give additional 20 ml/kg)
- Administer 2-5 packs platelets
- If platelets <100,000, give additional PRN to achieve Plt > 100,000
- STAT neurosurgery consult
- Consider TXA 15 mg/kg IV in 250 ml x 20 min if ongoing hemorrhage after above measures
Medication Dosing
Tranexamic acid 15mg/kg IV in 250mL over 20 min IV
